Accordingly, we found evidence of NLRP3 inflammasome activity within ischemic stroke infarcts during the chronic stage of liquefactive necrosis by way of a significant elevation of IL-18 at four and eight weeks following stroke. The gene discussed is NLRP3; the disease is Stroke.